查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2007808

先进生物材料市场预测至2034年：按材料类型、技术、应用、最终用户和地区分類的全球分析

Advanced Biomaterials Market Forecasts to 2034 - Global Analysis By Material Type (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, Natural Biomaterials, and Composite Biomaterials), Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球先进生物材料市场预计将在 2026 年达到 2,487 亿美元，到 2034 年达到 4,900 亿美元，预测期内复合年增长率为 8.0%。

先进生物材料是专为与生物系统相互作用而专门研发的医用和保健材料。这些材料旨在增强其在人体内的性能、相容性和功能性。它们广泛应用于医疗设备、植入、组织工程、药物传递系统和再生医学等领域。先进生物材料源自天然或合成原料，旨在促进癒合、修復受损组织或替代生物结构，同时确保其具有良好的生物相容性、耐久性，并最大限度地减少体内不良反应。

全球老化及相关退化性疾病

与老龄化相关的疾病，例如骨关节炎、心血管疾病和牙齿退化，需要关节重建、支架植入和人工植牙等外科手术。先进的生物材料，包括用于髋关节的耐磨聚乙烯和用于脊椎融合手术的生物活性陶瓷，对于老年患者这些手术的成功和长期稳定性至关重要。随着平均寿命的延长，人们对具有更高骨整合性和耐久性的植入的需求日益增长。这些人口结构的变化要求我们持续研究能够更真实地模拟天然组织特性并改善老年人生活品质的材料。

限制条件

原料高成本，製造流程复杂。

提取和提纯原料成本高昂，后续的精密加工、3D列印和表面改质等製造流程也需要先进且昂贵的设备和严格的品管。这些高昂的製造成本导致最终医疗设备价格高昂，可能阻碍其在价格敏感型市场的普及，并加重医疗保健预算的负担。对于小规模医疗设备製造商而言，生产先进生物材料所需的资本投入可能非常巨大，这可能会阻碍创新和市场准入。这种经济壁垒可能会减缓下一代植入技术的应用。

机会

再生医学和组织工程的扩展

快速发展的再生医学领域为先进生物材料带来了变革性的机会。目前，人们正从永久性植入转向支持人体自身癒合过程的暂时性生物可吸收支架。诸如可生物降解聚合物、生物活性玻璃和水凝胶等生物材料正被开发用于建造支架，以促进细胞增殖和组织再生，其应用范围广泛，涵盖创伤治疗到器官修復。随着复杂组织和器官工程研究的不断深入，对能够模拟细胞外基质并传递生物讯号的材料的需求将激增。这为不仅提供结构支撑而且能够积极参与癒合过程的材料开闢了新的可能性。

有害生物反应和植入失效的风险

即使经过严格的测试，长期生物相容性问题的风险仍然是一个重大威胁。植入材料可能引起慢性发炎、纤维囊形成或过敏反应，进而导致植入失败或需要再次手术。金属植入的腐蚀以及释放特定材料成分的聚合物劣化也是持续存在的挑战。因材料缺陷导致的大规模产品召回会损害公众信任，并导致监管机构加强审查。为了应对这一威胁，持续投资于表面改质技术以及开发具有更好血液相容性和组织整合性的下一代材料对于降低生物风险和确保患者安全至关重要。

新冠疫情的影响

新冠疫情对先进生物材料市场产生了双重影响。起初，全球部分手术的取消导致植入式医疗设备需求急剧下降，直接衝击了生物材料生产商。原料和特殊零件的供应链中断，生产也因此延误。然而，这场危机凸显了创新的重要性。用于抗病毒涂层和先进创伤护理的生物材料研究加速推进。随着后疫情时代对韧性医疗基础设施的日益重视，人们对本地化生产和研发的兴趣再次高涨，更加关注用于快速医疗响应解决方案的材料以及能够缩短住院时间的技术。

在预测期内，聚合物生物材料领域预计将占据最大的市场份额。

由于其柔软性、轻质和可调节的降解速率，预计在预测期内，聚合物基生物材料将占据最大的市场份额。这些材料应用广泛，涵盖药物传递系统、外科缝线以及耐用植入（例如用于脊椎融合手术的PEEK材料）等许多领域。该领域的成长主要得益于用于组织工程和可吸收医疗设备的生物降解聚合物的创新。这些材料可透过化学修饰以适应特定的生物相互作用，使其成为现代医疗设备中不可或缺的组成部分。随着抗菌涂层和刺激响应材料的开发，其临床效用正在扩大。

在预测期内，製药和生技公司板块预计将呈现最高的复合年增长率。

在预测期内，製药和生物技术公司板块预计将呈现最高的成长率，这主要得益于广泛应用于药物製剂和递送的先进生物材料。该板块需要高纯度聚合物来製造缓释剂、微球和植入，从而实现治疗药物的可控靶向递送。生物製药和个人化医疗的兴起推动了该板块的成长，而这些领域需要先进的递送方法来提高疗效和患者依从性。

市占率最大的地区：

在整个预测期内，北美预计将保持最大的市场份额，这主要得益于其先进的医疗基础设施、高昂的医疗费用支出以及众多大型医疗设备和生物材料公司的存在。该地区是技术创新中心，在再生医学和下一代植入拥有大量的研究经费。大量的关节重建和心血管手术，加上对先进手术的有利报销政策，确保了强劲的市场需求。

复合年增长率最高的地区：

在预测期内，亚太地区预计将呈现最高的复合年增长率，这主要得益于庞大的患者群体、新兴中产阶级的崛起及其医疗服务可及性的提高，以及各国政府对医疗基础设施现代化的巨额投资。中国、印度和日本等国的医疗设备製造业正蓬勃发展，日益成为重要的临床研究中心。慢性病盛行率的上升和人口老化的加剧也推动了对植入的需求。

免费客製化服务：

所有购买此报告的客户均可享受以下免费自订选项之一：

  • 企业概况
    • 对其他市场参与者（最多 3 家公司）进行全面分析
    • 对主要企业进行SWOT分析（最多3家公司）
  • 区域细分
    • 应客户要求，我们提供主要国家和地区的市场估算和预测，以及复合年增长率（註：需进行可行性检查）。
  • 竞争性标竿分析
    • 根据产品系列、地理覆盖范围和策略联盟对主要企业进行基准分析。

目录

第一章执行摘要

  • 市场概览及主要亮点
  • 驱动因素、挑战与机会
  • 竞争格局概述
  • 战略洞察与建议

第二章：研究框架

  • 研究目标和范围
  • 相关人员分析
  • 研究假设和限制
  • 调查方法

第三章 市场动态与趋势分析

  • 市场定义与结构
  • 主要市场驱动因素
  • 市场限制与挑战
  • 投资成长机会和重点领域
  • 产业威胁与风险评估
  • 技术与创新展望
  • 新兴市场/高成长市场
  • 监管和政策环境
  • 新冠疫情的影响及復苏前景

第四章：竞争环境与策略评估

  • 波特五力分析
    • 供应商的议价能力
    • 买方的议价能力
    • 替代品的威胁
    • 新进入者的威胁
    • 竞争公司之间的竞争
  • 主要企业市占率分析
  • 产品基准评效和效能比较

第五章：全球先进生物材料市场：依材料类型划分

  • 金属生物材料
    • 不銹钢
    • 钛及钛合金
    • 钴铬合金
    • 镁合金
  • 以聚合物为基础的生物材料
    • 聚甲基丙烯酸甲酯（PMMA）
    • 聚乙烯
    • 聚氯乙烯（PVC）
    • 硅橡胶
    • 聚醚醚酮（PEEK）
    • 可生物降解聚合物
  • 陶瓷生物材料
    • 氧化铝
    • 氧化锆
    • 磷酸钙
    • 生物活性玻璃
  • 天然生物材料
    • 胶原蛋白
    • 玻尿酸
    • 明胶
    • 几丁聚醣
    • 海藻酸盐
  • 复合生物材料

第六章 全球先进生物材料市场：依技术划分

  • 3D列印和生物列印
  • 表面改质技术
  • 基于奈米技术的生物材料
  • 静电纺丝技术

第七章 全球先进生物材料市场：依应用领域划分

  • 整形外科应用
    • 关节重建手术
    • 骨移植材料
    • 脊椎移植
  • 心血管应用
    • 支架
    • 心臟瓣膜
    • 血管移植
  • 牙科用途
    • 植入
    • 骨替代材料
    • 牙科修补
  • 眼科
  • 神经病学
  • 整形和重组外科
  • 组织工程与再生医学
  • 创伤治疗

第八章 全球先进生物材料市场：依最终用户划分

  • 医院和诊所
  • 门诊手术中心
  • 研究和学术机构
  • 製药和生物技术公司
  • 医疗设备製造商

第九章 全球先进生物材料市场：依地区划分

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 比利时
    • 瑞典
    • 瑞士
    • 波兰
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 马来西亚
    • 新加坡
    • 越南
    • 其他亚太国家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥伦比亚
    • 智利
    • 秘鲁
    • 其他南美国家
  • 世界其他地区（RoW）
    • 中东
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 卡达
      • 以色列
      • 其他中东国家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲国家

第十章 战略市场资讯

  • 工业价值网络和供应链评估
  • 空白区域和机会地图
  • 产品演进与市场生命週期分析
  • 通路、经销商和打入市场策略的评估

第十一章 产业趋势与策略倡议

  • 併购
  • 伙伴关係、联盟和合资企业
  • 新产品发布和认证
  • 扩大生产能力和投资
  • 其他策略倡议

第十二章：公司简介

  • Medtronic plc
  • Dentsply Sirona Inc.
  • Johnson & Johnson
  • Invibio Ltd.
  • Stryker Corporation
  • GELITA AG
  • Zimmer Biomet Holdings, Inc.
  • CoorsTek Inc.
  • Evonik Industries AG
  • CeramTec GmbH
  • BASF SE
  • Berkeley Advanced Biomaterials, Inc.
  • Corbion NV
  • Carpenter Technology Corporation
  • Celanese Corporation
Product Code: SMRC34680

According to Stratistics MRC, the Global Advanced Biomaterials Market is accounted for $248.7 billion in 2026 and is expected to reach $490.0 billion by 2034, growing at a CAGR of 8.0% during the forecast period. Advanced biomaterials are specially engineered materials designed to interact with biological systems for medical and healthcare applications. These materials are developed to enhance performance, compatibility, and functionality within the human body. They are widely used in medical devices, implants, tissue engineering, drug delivery systems, and regenerative medicine. Advanced biomaterials can be derived from natural or synthetic sources and are designed to support healing, repair damaged tissues, or replace biological structures while ensuring biocompatibility, durability, and minimal adverse reactions within the body.

Market Dynamics:

Driver:

Growing global geriatric population and associated degenerative diseases

Age-related conditions such as osteoarthritis, cardiovascular diseases, and dental degeneration necessitate surgical interventions like joint replacements, stents, and dental implants. Advanced biomaterials, including wear-resistant polyethylene for hips and bioactive ceramics for spinal fusion, are critical for the success and longevity of these procedures in older patients. As life expectancy rises, the demand for implants that offer enhanced osseointegration and durability grows. This demographic shift compels ongoing research into materials that can better mimic natural tissue properties and ensure a higher quality of life for the aging population.

Restraint

High cost of raw materials and complex manufacturing processes

Raw material extraction and purification are expensive, and subsequent manufacturing processes like precision machining, 3D printing, and surface modification require sophisticated, costly equipment and stringent quality controls. These high production costs translate to expensive final medical devices, which can limit accessibility in price-sensitive markets and strain healthcare budgets. For smaller medical device companies, the capital investment required for advanced biomaterial fabrication can be prohibitive, hindering innovation and market entry. This economic barrier can slow the widespread adoption of next-generation implant technologies.

Opportunity

Expansion of regenerative medicine and tissue engineering

The burgeoning field of regenerative medicine presents a transformative opportunity for advanced biomaterials. There is a growing shift from permanent implants to temporary, bioresorbable scaffolds that support the body's own healing process. Biomaterials like biodegradable polymers, bioactive glasses, and hydrogels are being engineered to create scaffolds that encourage cell growth and tissue regeneration for applications ranging from wound healing to organ repair. As research progresses towards complex tissue and organ engineering, the demand for materials that can mimic the extracellular matrix and deliver biological cues will skyrocket. This opens new frontiers for materials that actively participate in healing, rather than just providing structural support.

Threat:

Risk of adverse biological reactions and implant failures

Despite rigorous testing, the risk of long-term biocompatibility issues remains a significant threat. Implanted materials can sometimes trigger chronic inflammation, fibrous encapsulation, or allergic reactions, leading to implant failure and the need for revision surgeries. Issues such as corrosion of metallic implants or degradation of polymers releasing byproducts pose ongoing challenges. High-profile product recalls due to material shortcomings can erode public trust and lead to stricter regulatory scrutiny. This threat necessitates continuous investment in surface modification technologies and the development of next-generation materials with improved hemocompatibility and tissue integration to mitigate biological risks and ensure patient safety.

Covid-19 Impact

The COVID-19 pandemic had a dual impact on the advanced biomaterials market. Initially, the suspension of elective surgeries worldwide caused a sharp decline in demand for implantable devices, directly affecting biomaterial producers. Supply chains for raw materials and specialized components were disrupted, delaying production. However, the crisis also underscored the importance of innovation. It accelerated research into biomaterials for antiviral coatings and advanced wound care. The focus on resilient healthcare infrastructure post-pandemic has renewed interest in local manufacturing and R&D, with a greater emphasis on materials for rapid-response medical solutions and technologies that reduce hospital stay durations.

The polymeric biomaterials segment is expected to be the largest during the forecast period

The polymeric biomaterials segment is expected to account for the largest market share during the forecast period, due to their flexibility, lightweight nature, and tunable degradation rates. They are extensively used in applications ranging from drug delivery systems and surgical sutures to durable implants like PEEK for spinal fusion. The segment is driven by innovations in biodegradable polymers for tissue engineering and resorbable devices. Their ability to be chemically modified for specific biological interactions makes them indispensable for modern medical devices, with ongoing development in antimicrobial coatings and stimuli-responsive materials expanding their clinical utility.

The pharmaceutical & biotechnology companies segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the pharmaceutical & biotechnology companies segment is predicted to witness the highest growth rate, driven by advanced biomaterials, utilizing them extensively in drug formulation and delivery. They demand high-purity polymers for creating depots, microspheres, and implants that enable controlled, targeted release of therapeutics. This segment's growth is propelled by the rise of biologics and personalized medicine, which require sophisticated delivery vehicles to improve efficacy and patient compliance.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by its advanced healthcare infrastructure, high healthcare expenditure, and the presence of major medical device and biomaterial companies. The region is a hub for technological innovation, with significant research funding directed towards regenerative medicine and next-generation implants. High surgical volumes for joint replacements and cardiovascular procedures, coupled with favorable reimbursement policies for advanced procedures, ensure robust market demand.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, propelled by large patient pools, a rising middle class with greater access to healthcare, and significant government investments in modernizing healthcare infrastructure. Countries like China, India, and Japan are seeing a surge in medical device manufacturing and are increasingly becoming hubs for clinical research. The growing prevalence of chronic diseases and a rapidly aging population are driving demand for implants.

Key players in the market

Some of the key players in Advanced Biomaterials Market include Medtronic plc, Dentsply Sirona Inc., Johnson & Johnson, Invibio Ltd., Stryker Corporation, GELITA AG, Zimmer Biomet Holdings, Inc., CoorsTek Inc., Evonik Industries AG, CeramTec GmbH, BASF SE, Berkeley Advanced Biomaterials, Inc., Corbion N.V., Carpenter Technology Corporation, and Celanese Corporation.

Key Developments:

In November 2025, BASF announced the expansion of its Alkyl Polyglucosides (APGs) footprint in Asia with a new plant at the Bangpakong site in Thailand. The enhancement is a strategic response to strengthen its position in growth geography and serve customers with greater agility and more flexibility from a robust regional network.

In September 2024, Evonik launched a new high-performance PEEK filament for medical 3D printing, specifically designed for patient-specific, load-bearing implants. This new material offers enhanced radiolucency and mechanical strength, streamlining the production of customized spinal and trauma devices.

Material Types Covered:

  • Metallic Biomaterials
  • Polymeric Biomaterials
  • Ceramic Biomaterials
  • Natural Biomaterials
  • Composite Biomaterials

Technologies Covered:

  • 3D Printing & Bioprinting
  • Surface Modification Technologies
  • Nanotechnology-based Biomaterials
  • Electrospinning Techniques

Applications Covered:

  • Orthopedic Applications
  • Cardiovascular Applications
  • Dental Applications
  • Ophthalmology
  • Neurology
  • Plastic & Reconstructive Surgery
  • Tissue Engineering & Regenerative Medicine
  • Wound Healing

End Users Covered:

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Research & Academic Institutes
  • Pharmaceutical & Biotechnology Companies
  • Medical Device Manufacturers

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Advanced Biomaterials Market, By Material Type

  • 5.1 Metallic Biomaterials
    • 5.1.1 Stainless Steel
    • 5.1.2 Titanium & Titanium Alloys
    • 5.1.3 Cobalt-Chromium Alloys
    • 5.1.4 Magnesium Alloys
  • 5.2 Polymeric Biomaterials
    • 5.2.1 Polymethyl Methacrylate (PMMA)
    • 5.2.2 Polyethylene
    • 5.2.3 Polyvinyl Chloride (PVC)
    • 5.2.4 Silicone Rubber
    • 5.2.5 Polyether Ether Ketone (PEEK)
    • 5.2.6 Biodegradable Polymers
  • 5.3 Ceramic Biomaterials
    • 5.3.1 Aluminum Oxide
    • 5.3.2 Zirconia
    • 5.3.3 Calcium Phosphate
    • 5.3.4 Bioactive Glass
  • 5.4 Natural Biomaterials
    • 5.4.1 Collagen
    • 5.4.2 Hyaluronic Acid
    • 5.4.3 Gelatin
    • 5.4.4 Chitosan
    • 5.4.5 Alginate
  • 5.5 Composite Biomaterials

6 Global Advanced Biomaterials Market, By Technology

  • 6.1 3D Printing & Bioprinting
  • 6.2 Surface Modification Technologies
  • 6.3 Nanotechnology-based Biomaterials
  • 6.4 Electrospinning Techniques

7 Global Advanced Biomaterials Market, By Application

  • 7.1 Orthopedic Applications
    • 7.1.1 Joint Replacement
    • 7.1.2 Bone Grafts
    • 7.1.3 Spinal Implants
  • 7.2 Cardiovascular Applications
    • 7.2.1 Stents
    • 7.2.2 Heart Valves
    • 7.2.3 Vascular Grafts
  • 7.3 Dental Applications
    • 7.3.1 Dental Implants
    • 7.3.2 Bone Substitutes
    • 7.3.3 Dental Prosthetics
  • 7.4 Ophthalmology
  • 7.5 Neurology
  • 7.6 Plastic & Reconstructive Surgery
  • 7.7 Tissue Engineering & Regenerative Medicine
  • 7.8 Wound Healing

8 Global Advanced Biomaterials Market, By End User

  • 8.1 Hospitals & Clinics
  • 8.2 Ambulatory Surgical Centers
  • 8.3 Research & Academic Institutes
  • 8.4 Pharmaceutical & Biotechnology Companies
  • 8.5 Medical Device Manufacturers

9 Global Advanced Biomaterials Market, By Geography

  • 9.1 North America
    • 9.1.1 United States
    • 9.1.2 Canada
    • 9.1.3 Mexico
  • 9.2 Europe
    • 9.2.1 United Kingdom
    • 9.2.2 Germany
    • 9.2.3 France
    • 9.2.4 Italy
    • 9.2.5 Spain
    • 9.2.6 Netherlands
    • 9.2.7 Belgium
    • 9.2.8 Sweden
    • 9.2.9 Switzerland
    • 9.2.10 Poland
    • 9.2.11 Rest of Europe
  • 9.3 Asia Pacific
    • 9.3.1 China
    • 9.3.2 Japan
    • 9.3.3 India
    • 9.3.4 South Korea
    • 9.3.5 Australia
    • 9.3.6 Indonesia
    • 9.3.7 Thailand
    • 9.3.8 Malaysia
    • 9.3.9 Singapore
    • 9.3.10 Vietnam
    • 9.3.11 Rest of Asia Pacific
  • 9.4 South America
    • 9.4.1 Brazil
    • 9.4.2 Argentina
    • 9.4.3 Colombia
    • 9.4.4 Chile
    • 9.4.5 Peru
    • 9.4.6 Rest of South America
  • 9.5 Rest of the World (RoW)
    • 9.5.1 Middle East
      • 9.5.1.1 Saudi Arabia
      • 9.5.1.2 United Arab Emirates
      • 9.5.1.3 Qatar
      • 9.5.1.4 Israel
      • 9.5.1.5 Rest of Middle East
    • 9.5.2 Africa
      • 9.5.2.1 South Africa
      • 9.5.2.2 Egypt
      • 9.5.2.3 Morocco
      • 9.5.2.4 Rest of Africa

10 Strategic Market Intelligence

  • 10.1 Industry Value Network and Supply Chain Assessment
  • 10.2 White-Space and Opportunity Mapping
  • 10.3 Product Evolution and Market Life Cycle Analysis
  • 10.4 Channel, Distributor, and Go-to-Market Assessment

11 Industry Developments and Strategic Initiatives

  • 11.1 Mergers and Acquisitions
  • 11.2 Partnerships, Alliances, and Joint Ventures
  • 11.3 New Product Launches and Certifications
  • 11.4 Capacity Expansion and Investments
  • 11.5 Other Strategic Initiatives

12 Company Profiles

  • 12.1 Medtronic plc
  • 12.2 Dentsply Sirona Inc.
  • 12.3 Johnson & Johnson
  • 12.4 Invibio Ltd.
  • 12.5 Stryker Corporation
  • 12.6 GELITA AG
  • 12.7 Zimmer Biomet Holdings, Inc.
  • 12.8 CoorsTek Inc.
  • 12.9 Evonik Industries AG
  • 12.10 CeramTec GmbH
  • 12.11 BASF SE
  • 12.12 Berkeley Advanced Biomaterials, Inc.
  • 12.13 Corbion N.V.
  • 12.14 Carpenter Technology Corporation
  • 12.15 Celanese Corporation

List of Tables

  • Table 1 Global Advanced Biomaterials Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Advanced Biomaterials Market Outlook, By Material Type (2023-2034) ($MN)
  • Table 3 Global Advanced Biomaterials Market Outlook, By Metallic Biomaterials (2023-2034) ($MN)
  • Table 4 Global Advanced Biomaterials Market Outlook, By Stainless Steel (2023-2034) ($MN)
  • Table 5 Global Advanced Biomaterials Market Outlook, By Titanium & Titanium Alloys (2023-2034) ($MN)
  • Table 6 Global Advanced Biomaterials Market Outlook, By Cobalt-Chromium Alloys (2023-2034) ($MN)
  • Table 7 Global Advanced Biomaterials Market Outlook, By Magnesium Alloys (2023-2034) ($MN)
  • Table 8 Global Advanced Biomaterials Market Outlook, By Polymeric Biomaterials (2023-2034) ($MN)
  • Table 9 Global Advanced Biomaterials Market Outlook, By Polymethyl Methacrylate (PMMA) (2023-2034) ($MN)
  • Table 10 Global Advanced Biomaterials Market Outlook, By Polyethylene (2023-2034) ($MN)
  • Table 11 Global Advanced Biomaterials Market Outlook, By Polyvinyl Chloride (PVC) (2023-2034) ($MN)
  • Table 12 Global Advanced Biomaterials Market Outlook, By Silicone Rubber (2023-2034) ($MN)
  • Table 13 Global Advanced Biomaterials Market Outlook, By Polyether Ether Ketone (PEEK) (2023-2034) ($MN)
  • Table 14 Global Advanced Biomaterials Market Outlook, By Biodegradable Polymers (2023-2034) ($MN)
  • Table 15 Global Advanced Biomaterials Market Outlook, By Ceramic Biomaterials (2023-2034) ($MN)
  • Table 16 Global Advanced Biomaterials Market Outlook, By Aluminum Oxide (2023-2034) ($MN)
  • Table 17 Global Advanced Biomaterials Market Outlook, By Zirconia (2023-2034) ($MN)
  • Table 18 Global Advanced Biomaterials Market Outlook, By Calcium Phosphate (2023-2034) ($MN)
  • Table 19 Global Advanced Biomaterials Market Outlook, By Bioactive Glass (2023-2034) ($MN)
  • Table 20 Global Advanced Biomaterials Market Outlook, By Natural Biomaterials (2023-2034) ($MN)
  • Table 21 Global Advanced Biomaterials Market Outlook, By Collagen (2023-2034) ($MN)
  • Table 22 Global Advanced Biomaterials Market Outlook, By Hyaluronic Acid (2023-2034) ($MN)
  • Table 23 Global Advanced Biomaterials Market Outlook, By Gelatin (2023-2034) ($MN)
  • Table 24 Global Advanced Biomaterials Market Outlook, By Chitosan (2023-2034) ($MN)
  • Table 25 Global Advanced Biomaterials Market Outlook, By Alginate (2023-2034) ($MN)
  • Table 26 Global Advanced Biomaterials Market Outlook, By Composite Biomaterials (2023-2034) ($MN)
  • Table 27 Global Advanced Biomaterials Market Outlook, By Technology (2023-2034) ($MN)
  • Table 28 Global Advanced Biomaterials Market Outlook, By 3D Printing & Bioprinting (2023-2034) ($MN)
  • Table 29 Global Advanced Biomaterials Market Outlook, By Surface Modification Technologies (2023-2034) ($MN)
  • Table 30 Global Advanced Biomaterials Market Outlook, By Nanotechnology-based Biomaterials (2023-2034) ($MN)
  • Table 31 Global Advanced Biomaterials Market Outlook, By Electrospinning Techniques (2023-2034) ($MN)
  • Table 32 Global Advanced Biomaterials Market Outlook, By Application (2023-2034) ($MN)
  • Table 33 Global Advanced Biomaterials Market Outlook, By Orthopedic Applications (2023-2034) ($MN)
  • Table 34 Global Advanced Biomaterials Market Outlook, By Joint Replacement (2023-2034) ($MN)
  • Table 35 Global Advanced Biomaterials Market Outlook, By Bone Grafts (2023-2034) ($MN)
  • Table 36 Global Advanced Biomaterials Market Outlook, By Spinal Implants (2023-2034) ($MN)
  • Table 37 Global Advanced Biomaterials Market Outlook, By Cardiovascular Applications (2023-2034) ($MN)
  • Table 38 Global Advanced Biomaterials Market Outlook, By Stents (2023-2034) ($MN)
  • Table 39 Global Advanced Biomaterials Market Outlook, By Heart Valves (2023-2034) ($MN)
  • Table 40 Global Advanced Biomaterials Market Outlook, By Vascular Grafts (2023-2034) ($MN)
  • Table 41 Global Advanced Biomaterials Market Outlook, By Dental Applications (2023-2034) ($MN)
  • Table 42 Global Advanced Biomaterials Market Outlook, By Dental Implants (2023-2034) ($MN)
  • Table 43 Global Advanced Biomaterials Market Outlook, By Bone Substitutes (2023-2034) ($MN)
  • Table 44 Global Advanced Biomaterials Market Outlook, By Dental Prosthetics (2023-2034) ($MN)
  • Table 45 Global Advanced Biomaterials Market Outlook, By Ophthalmology (2023-2034) ($MN)
  • Table 46 Global Advanced Biomaterials Market Outlook, By Neurology (2023-2034) ($MN)
  • Table 47 Global Advanced Biomaterials Market Outlook, By Plastic & Reconstructive Surgery (2023-2034) ($MN)
  • Table 48 Global Advanced Biomaterials Market Outlook, By Tissue Engineering & Regenerative Medicine (2023-2034) ($MN)
  • Table 49 Global Advanced Biomaterials Market Outlook, By Wound Healing (2023-2034) ($MN)
  • Table 50 Global Advanced Biomaterials Market Outlook, By End User (2023-2034) ($MN)
  • Table 51 Global Advanced Biomaterials Market Outlook, By Hospitals & Clinics (2023-2034) ($MN)
  • Table 52 Global Advanced Biomaterials Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
  • Table 53 Global Advanced Biomaterials Market Outlook, By Research & Academic Institutes (2023-2034) ($MN)
  • Table 54 Global Advanced Biomaterials Market Outlook, By Pharmaceutical & Biotechnology Companies (2023-2034) ($MN)
  • Table 55 Global Advanced Biomaterials Market Outlook, By Medical Device Manufacturers (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.